000 02129nam  2200409zi 4500
0019.907190
003CaOODSP
00520221107181325
006m     o  d f      
007cr |n|||||||||
008220121t20192019oncd    obs  f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aCS82-625/2019001-8E-PDF
24500|aPain relief medication containing opioids, 2018.
264 1|a[Ottawa] : |bStatistics Canada = Statistique Canada, |c2019.
264 4|c©2019
300 |a1 online resource (11 pages) : |bcharts.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aHealth fact sheets
500 |a"Release date: June 25, 2019."
500 |aCaption title.
500 |aIssued also in HTML format.
500 |aIssued also in French under title: Médicaments antidouleur contenant des opioïdes, 2018.
504 |aIncludes bibliographical references (page 9).
520 |a"Opioid use has emerged as a public health issue in Canada in recent years following a rise in opioid-related harms, such as increased hospitalizations and deaths linked to overdose. In 2018, the Canadian Community Health Survey (CCHS) asked Canadians about their prescription and non-prescription use of pain relief medications containing opioids, such as codeine or morphine. Overall, 40.5% of Canadians aged 15 years and older (roughly 11.8 million people) reported they had used this type of pain relief product in their lifetime"--Page 3.
650 0|aOpioid abuse|zCanada|vStatistics.
650 0|aDrug utilization|zCanada|vStatistics.
655 7|aStatistics|2lcgft
7102 |aStatistics Canada, |eissuing body.
77508|tMédicaments antidouleur contenant des opioïdes, 2018.|w(CaOODSP)9.907198
830#0|aHealth fact sheets.|w(CaOODSP)9.507525
85640|qPDF|s1.76 MB|uhttps://publications.gc.ca/collections/collection_2022/statcan/82-625-x/82-625-2019001-8-eng.pdf
8564 |qHTML|sN/A|uhttps://www150.statcan.gc.ca/n1/pub/82-625-x/2019001/article/00008-eng.htm